Novick A C, Streem S B
Department of Urology, Cleveland Clinic Foundation, Ohio 44195.
J Urol. 1992 Jun;147(6):1488-90. doi: 10.1016/s0022-5347(17)37604-8.
We reviewed the long-term outcome of nephron sparing surgery in 9 patients with localized bilateral renal cell carcinoma and von Hippel-Lindau disease. One patient died of metastatic renal cell carcinoma 43 months postoperatively. One patient has not had recurrent tumor and was alive at 74 months postoperatively. The remaining 7 patients (mean followup 88 months) had local recurrence of tumor in the operated kidney and a secondary renal operation was done in 6 of them. Overall, 6 patients are free of tumor but only 3 of them retain functioning native renal parenchyma. We conclude that the results of nephron sparing surgery in patients with renal cell carcinoma and von Hippel-Lindau disease are less satisfactory than in patients with sporadic renal cell carcinoma.
我们回顾了9例局限性双侧肾细胞癌合并冯·希佩尔-林道病患者行保留肾单位手术的长期疗效。1例患者术后43个月死于转移性肾细胞癌。1例患者未出现肿瘤复发,术后74个月仍存活。其余7例患者(平均随访88个月)手术侧肾脏出现肿瘤局部复发,其中6例接受了二次肾脏手术。总体而言,6例患者无肿瘤,但其中只有3例保留了有功能的肾实质。我们得出结论,肾细胞癌合并冯·希佩尔-林道病患者行保留肾单位手术的结果不如散发性肾细胞癌患者理想。